Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Other ICR Research
  • View item
  • Home
  • ICR Divisions
  • Other ICR Research
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

De-escalating Surgery Among Patients with HER2 + and Triple Negative Breast Cancer.

Thumbnail
View/Open
CBCR-S-22-00022.pdf (673.0Kb)
Date
2022-07-27
ICR Author
Tasoulis, Marios
Author
Tasoulis, M-K
Heil, J
Kuerer, HM
Type
Journal Article
Metadata
Show full item record
Abstract
Purpose of Review: De-escalation of surgery has been central in the evolution of multidisciplinary management of breast cancer. Advances in oncology and increasing use of neoadjuvant chemotherapy (NACT) have opened opportunities for further surgical de-escalation especially for HER2 + and triple negative (TN) disease. The aim of this review is to discuss the recent data on de-escalation of surgery as well as the future directions. Recent Findings: Patients with TN and HER2 + breast cancer with excellent response to NACT would be the ideal candidates for surgical de-escalation. Post-NACT image-guided biopsy, potentially combined with machine learning algorithms, may accurately identify patients achieving pathologic complete response that would be eligible for clinical trials assessing safety of omission of breast and axillary surgery. Summary: Multidisciplinary research is required to further support results of preliminary studies. Current data point towards a future when even less or no surgery may be required for exceptional responders.
URI
https://repository.icr.ac.uk/handle/internal/5271
DOI
https://doi.org/10.1007/s12609-022-00453-3
https://doi.org/10.1007/s12609-022-00453-3
 
Collections
  • Other ICR Research
Subject
Breast cancer
Breast surgery
HER2 positive
Surgical de-escalation
Triple negative
Language
eng
Date accepted
2022-07-16
License start date
2022-07-27
Citation
Current Breast Cancer Reports, 2022, pp. 1 - 7
Publisher
SPRINGER

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.